China Resources Pharmaceutical Group Limited (3320.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 27.98B |
| Enterprise Value | 102.24B |
| P/E Ratio | 6.37 |
| PEG Ratio | 0.26 |
| Price/Sales Ratio | 0.1 |
| Price/Book Ratio | 0.5 |
| Enterprise/Revenue | 0.34 |
| Enterprise/EBITDA | 5.85 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0.02 |
| Operating Margin | 0.05 |
AD
Management Effectiveness
| Return On Assets | 0.01 |
| Return On Equity | 0.08 |
Income Statement
| Revenue | 300.01B |
| Revenue/Share | 47.41 |
| Gross Profit | 49.53B |
| EBITDA | 17.7B |
| Net Income | 4.5B |
| Diluted EPS | 0.72 |
Balance Sheet
| Total Cash | 31.05B |
| Total Cash/Share | 7.01 |
| Total Debt | 104.87B |
| Total Debt/Equity | 1.83 |
| Current Ratio | 1.42 |
| Book Value Per Share | 20.83 |
Price History
| 52-Week Change | -12.23 |
| 52-Week High | 6.53 |
| 52-Week Low | 4.34 |
| Moving Average 50 Days | 5.24 |
| Moving Average 200 Days | 4.9 |
Statistics
| Average Volume | 19.88M |
| Shares Outstanding | 6.28B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.22 |
| Trailing Annual Dividend Yield | 4.82 |
| Payout Ratio | 0.19 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
